The Effects of Anti-Viral Therapy on the Clinical Status, Quality of Life, and Survival of Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection
Phase of Trial: Phase III
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C; Liver cirrhosis
- Focus Therapeutic Use
- 15 Mar 2018 Planned End Date changed from 1 Dec 2018 to 1 Feb 2019.
- 15 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 01 Nov 2016 Status changed from not yet recruiting to recruiting.